World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
UK
2026

D-Index & Metrics

Best Scientists

D-Index
196
Citations
315652
World Ranking
332
National Ranking
37

Medicine

D-Index
198
Citations
330975
World Ranking
192
National Ranking
25

Research.com Recognitions

  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award
  • 2015 - Fellow of the Royal Society, United Kingdom
  • 2007 - J. Allyn Taylor International Prize in Medicine, Robarts Research Institute

Overview

Rory Collins is a researcher affiliated with the University of Oxford in the United Kingdom. Their work encompasses a broad range of topics within medicine and related fields, combining expertise in genetics, cardiovascular medicine, and molecular biology.

Their primary fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, their subfields of study are:

  • Genetics
  • Cardiology and Cardiovascular Medicine
  • Molecular Biology
  • Surgery
  • Endocrinology, Diabetes and Metabolism

The main topics addressed in their research cover:

  • Genetic Associations and Epidemiology
  • Lipoproteins and Cardiovascular Health
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Blood Pressure and Hypertension Studies
  • Genomics and Rare Diseases
  • Cardiac, Anesthesia and Surgical Outcomes

Rory Collins has coauthored numerous scientific publications with several frequent collaborators. Their most common coauthors include:

  • Jun Lv (78 joint publications)
  • Zhengming Chen (67 joint publications)
  • Canqing Yu (65 joint publications)
  • Robert Clarke (65 joint publications)
  • Huaidong Du (60 joint publications)

The venues in which they most often publish include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • European Heart Journal
  • The Lancet
  • International Journal of Epidemiology
  • Nature Communications

Some notable recent papers authored or coauthored by Rory Collins are:

  • "SARS-CoV-2 is associated with changes in brain structure in UK Biobank" (2022, Nature)
  • "Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis" (2021, The Lancet)
  • "COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England" (2020, The Lancet)
  • "The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions" (2020, Nature Communications)
  • "A brief history of human disease genetics" (2020, Nature)

Rory Collins has received recognition including:

  • Fellow of the Royal Society, United Kingdom (2015)
  • J. Allyn Taylor International Prize in Medicine, Robarts Research Institute (2007)

Best Publications

  • Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

    Sarah Lewington;Robert Clarke;Nawab Qizilbash;Richard Peto

  • UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age

    Cathie Sudlow;John Edward Gallacher;Naomi Allen;Valerie Beral

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

    C Baigent;C Sudlow;R Collins;R Peto

  • Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

    C Baigent;A Keech;P M Kearney;L Blackwell

  • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

    A. Tonkin;P. Alyward;D. Colquhoun;P. Glasziou

  • Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

    C Baigent;L Blackwell;J Emberson

  • COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

    R Altman;L Carreras;R Diaz;E Figueroa

  • Tamoxifen for early breast cancer: An overview of the randomised trials

    M Clarke;R Collins;C Davies

  • Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

    Gary Whitlock;Sarah Lewington;Paul Sherliker

  • Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

    S Macmahon;R Peto;J E Cutler;R Collins

  • Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

    M Clarke;R Collins;S Darby;C Davies

  • Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context

    R Collins;R Peto;S MacMahon;P Hebert

  • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

    Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel

  • Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

    S. MacMahon;B. Neal;C. Tzourio;A. Rodgers

  • Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

    R B Sleight;P. Sleight;S Parish;P Appleby

  • MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

    Rory Collins;Jane Armitage;Sarah Parish;Peter Sleigh

  • Beta blockade during and after myocardial infarction: an overview of the randomized trials

    Salirn Yusuf;Richard Peto;John Lewis;Rory Collins

  • Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

    E. E. Calle;C. W. Heath;R. J. Coates;J. M. Liff

  • Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

    Colin Baigent;Lisa Blackwell;Rory Collins

Frequent Co-Authors

Richard Peto
Richard Peto University of Oxford
Robert Clarke
Robert Clarke University of Oxford
Zhengming Chen
Zhengming Chen University of Oxford
Colin Baigent
Colin Baigent University of Oxford
Liming Li
Liming Li Peking University
Jonathan Emberson
Jonathan Emberson University of Oxford
John Danesh
John Danesh University of Cambridge
Peter Sleight
Peter Sleight John Radcliffe Hospital
Hugh Watkins
Hugh Watkins University of Oxford
Derrick A. Bennett
Derrick A. Bennett University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn't always begin with traditional medical school. Many students and professionals are opting for flexible, online pathways to expand their healthcare expertise and advance their careers. There are several accredited programs available that cater to different backgrounds and ambitions—whether you're just starting out, or looking to reach leadership roles in healthcare.

Registered nurses can enhance their credentials and earning potential by enrolling in cheapest rn to bsn online programs, which offer a convenient and affordable way to earn a Bachelor of Science in Nursing. Those looking for advanced practice roles often consider the most affordable nurse practitioner programs, which can open doors to specialized clinical positions.

For RNs interested specifically in furthering their education without breaking the bank, exploring rn to bsn online cost can help you find the best-value options. Additionally, healthcare professionals aspiring to academic or research leadership roles may consider pursuing an online phd nursing for advanced expertise and new career opportunities.

Best Scientists Citing Rory Collins

Trending Scientists

Recently Published Articles